ArticleHuman vaccines & immunotherapeutics2024
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation.
Jie Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it